Fund Holdings — Lion Point Capital, LP

Total Portfolio Value
$16.73M
Total Bought
$677.4K
Total Sold
$909.8K
Net Transaction
-$232.4K
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)67,50067,50008901,2587.52%+369
ROYALTY PHARMA PLC(RPRX)21,40021,40008271,0276.14%+200
PRAXIS PRECISION MEDICINES I(PRAX)4,4504,45001,3121,4348.57%+122
GERON CORP(GERN)578,000578,00007638615.15%+98
SYNDAX PHARMACEUTICALS INC(SNDX)36,00036,00007568415.03%+85
EDGEWISE THERAPEUTICS INC(EWTX)9,1009,10002262871.71%+61
LANTHEUS HLDGS INC(LNTH)5,5005,50003664172.49%+51
COMPASS PATHWAYS PLC(CMPS)58,00080,000+22,0004004422.64%+42
VIATRIS INC(VTRS)27,70027,70003453742.24%+29
INNOVIVA INC(INVA)8,2008,20001641911.14%+27
ARDELYX INC128,650128,65007507714.61%+21
GH RESEARCH PLC(GHRS)10,20010,20001301430.86%+14
SAREPTA THERAPEUTICS INC(SRPT)28,50028,50006136203.71%+7
ROCKET PHARMACEUTICALS INC(RCKT)86,00086,00003023081.84%+6
JANUX THERAPEUTICS INC(JANX)19,00019,00002622641.58%+2
MERSANA THERAPEUTICS INC1000-10030—-3
BRIDGEBIO PHARMA INC(BBIO)5,0005,00003823712.22%-11
SPRUCE BIOSCIENCES INC1,0001,000087650.39%-22
DYNE THERAPEUTICS INC(DYN)18,00018,00003523261.95%-26
ARCUTIS BIOTHERAPEUTICS INC(ARQT)5,2505,25001521240.74%-29
INNATE PHARMA S A(IPHA)81,15181,15101421040.62%-38
PACIRA BIOSCIENCES INC(PCRX)13,50013,50003493051.82%-44
HUMACYTE INC(HUMA)500,000650,000+150,0004803942.36%-86
MINERALYS THERAPEUTICS INC(MLYS)10,50010,50003812841.70%-97
KURA ONCOLOGY INC(KURA)46,00046,00004783742.24%-104
UNIQURE NV(QURE)14,70014,70003522401.44%-111
AZENTA INC(AZTA)9,7009,70003232051.22%-118
DISC MEDICINE INC(IRON)8,1008,10006435183.10%-125
MINERVA NEUROSCIENCES INC(NERV)35,0000-35,0001410—-141
BIOHAVEN LTD(BHVN)51,70051,70005844372.61%-146
REGENXBIO INC(RGNX)26,60026,60003832231.33%-160
CUE BIOPHARMA INC(CUE)2,202,8542,202,85406735063.03%-166
FENNEC PHARMACEUTICALS INC(FENC)112,434112,43408666914.13%-174
BENITEC BIOPHARMA INC(BNTC)62,00062,00008356603.95%-175
SERES THERAPEUTICS INC(MCRB)31,57031,57004702801.67%-190
VENTYX BIOSCIENCES INC41,5000-41,5003750—-375
DAY ONE BIOPHARMACEUTICALS I
COM
42,0000-42,0003910—-391
JASPER THERAPEUTICS INC(JSPR)465,000465,00008514072.44%-444
MILESTONE PHARMACEUTICALS IN(MIST)755,000820,000+65,0001,5259765.83%-549
Page 1 of 1
Lion Point Capital, LP — 13F Holdings — Q1 2026 | TickerTrail